Vita Life Sciences Limited (ASX:VLS)
Australia
· Delayed Price · Currency is AUD 1.815
+0.065 (3.71%)
Apr 30, 2025, 10:50 AM AEST
Vita Life Sciences Income Statement
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 79.51 | 73.43 | 66.89 | 57.1 | 46.48 | Upgrade
|
| Revenue Growth (YoY) | 8.28% | 9.78% | 17.14% | 22.85% | 9.49% | Upgrade
|
| Cost of Revenue | 32.26 | 31.05 | 27.15 | 22.29 | 17.21 | Upgrade
|
| Gross Profit | 47.24 | 42.38 | 39.74 | 34.81 | 29.27 | Upgrade
|
| Selling, General & Admin | 35.19 | 30.17 | 28.7 | 23.54 | 21.38 | Upgrade
|
| Other Operating Expenses | 0.4 | 0.34 | 0.31 | 0.26 | 0.33 | Upgrade
|
| Operating Expenses | 35.59 | 30.51 | 29.01 | 23.79 | 21.7 | Upgrade
|
| Operating Income | 11.66 | 11.88 | 10.73 | 11.02 | 7.57 | Upgrade
|
| Interest Expense | -0.05 | -0.06 | - | -0.06 | -0.13 | Upgrade
|
| Interest & Investment Income | 1.04 | 0.56 | 0.14 | 0.14 | 0.19 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.07 | -0.21 | -0.12 | 0.01 | -0.06 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.08 | -0.05 | -0 | 0.11 | 0.61 | Upgrade
|
| EBT Excluding Unusual Items | 12.64 | 12.12 | 10.75 | 11.21 | 8.18 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | -0 | -0 | Upgrade
|
| Asset Writedown | - | 0.34 | -0.01 | -0.01 | -0.02 | Upgrade
|
| Pretax Income | 12.64 | 12.45 | 10.74 | 11.2 | 8.16 | Upgrade
|
| Income Tax Expense | 3.86 | 3.37 | 3.4 | 2.95 | 2.3 | Upgrade
|
| Earnings From Continuing Operations | 8.78 | 9.08 | 7.34 | 8.25 | 5.86 | Upgrade
|
| Minority Interest in Earnings | 0.01 | 0 | -0.26 | 0.05 | 0.23 | Upgrade
|
| Net Income | 8.78 | 9.08 | 7.08 | 8.29 | 6.09 | Upgrade
|
| Net Income to Common | 8.78 | 9.08 | 7.08 | 8.29 | 6.09 | Upgrade
|
| Net Income Growth | -3.26% | 28.18% | -14.57% | 36.07% | 94.32% | Upgrade
|
| Shares Outstanding (Basic) | 56 | 54 | 53 | 53 | 53 | Upgrade
|
| Shares Outstanding (Diluted) | 56 | 55 | 54 | 53 | 53 | Upgrade
|
| Shares Change (YoY) | 1.70% | 1.30% | 1.64% | 0.97% | -3.93% | Upgrade
|
| EPS (Basic) | 0.16 | 0.17 | 0.13 | 0.16 | 0.12 | Upgrade
|
| EPS (Diluted) | 0.16 | 0.17 | 0.13 | 0.16 | 0.12 | Upgrade
|
| EPS Growth | -4.88% | 26.52% | -15.95% | 34.80% | 102.22% | Upgrade
|
| Free Cash Flow | 5.96 | 12.32 | 2.64 | 5.73 | 7.46 | Upgrade
|
| Free Cash Flow Per Share | 0.11 | 0.23 | 0.05 | 0.11 | 0.14 | Upgrade
|
| Dividend Per Share | 0.100 | 0.090 | 0.060 | 0.058 | 0.043 | Upgrade
|
| Dividend Growth | 11.11% | 50.00% | 4.35% | 35.29% | 13.33% | Upgrade
|
| Gross Margin | 59.42% | 57.72% | 59.41% | 60.96% | 62.98% | Upgrade
|
| Operating Margin | 14.66% | 16.17% | 16.04% | 19.29% | 16.28% | Upgrade
|
| Profit Margin | 11.05% | 12.37% | 10.59% | 14.52% | 13.11% | Upgrade
|
| Free Cash Flow Margin | 7.49% | 16.78% | 3.94% | 10.04% | 16.04% | Upgrade
|
| EBITDA | 11.99 | 12.11 | 10.98 | 11.24 | 7.81 | Upgrade
|
| EBITDA Margin | 15.08% | 16.49% | 16.41% | 19.69% | 16.80% | Upgrade
|
| D&A For EBITDA | 0.33 | 0.23 | 0.25 | 0.23 | 0.24 | Upgrade
|
| EBIT | 11.66 | 11.88 | 10.73 | 11.02 | 7.57 | Upgrade
|
| EBIT Margin | 14.66% | 16.17% | 16.04% | 19.29% | 16.28% | Upgrade
|
| Effective Tax Rate | 30.55% | 27.09% | 31.64% | 26.37% | 28.14% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.